Bluemantle, Royal London Asset Management and University Hospital South Manchester Foundation Trust are to develop one of Europe’s biggest biotech clusters.
The trio has struck a deal to pool its land assets to develop a major healthcare and commercial life-science
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
